Trial intelligence / Profile preview

ASPIRE Pilot: HPV Self-collection vs VIA for Cervical Cancer Screening

NCT02029794Completed

Sponsor
University of British Columbia
Start
Mar 2014
Primary completion
Jun 2014
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by University of British Columbia. Primary endpoint: Histologically confirmed cervical intra-epithelial lesions grade 2 (CIN2) or greater at 12 months. Started Mar 2014; status: completed.

Beyond the preview

Go deeper on NCT02029794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02029794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call